Correlation of Euroscore-II, STS Risk Scoring Systems and Frailty Tests with Cardiac Histopathological Findings in Coronary Bypass Surgery
1 other identifier
observational
50
1 country
1
Brief Summary
Various risk classification systems are used to predict postoperative mortality and morbidity development in cardiac surgery. Risk calculation with these systems is a guide in determining preoperative strategies, performing cost analyses, creating different treatment options and classifying diseases according to their severity. In recent years, tests defined as Frailty, which show how independently a person can perform daily living activities and are also associated with postoperative complications, have also been used. These tests allow for a personalized approach such as determining the most appropriate treatment options and pre- and postoperative rehabilitation. This study aims to evaluate the risk scores used to predict mortality during the preoperative preparation process in cases planned for elective Coronary Artery Bypass Graft (CABG) using the European System for Cardiac Operative Risk Evaluation (Euroscore)-II and Society of Thoracic Surgeons (STS) as well as Frailty with the Katz Index and modified Rockwood Clinical Frailty Scale, and to correlate the findings obtained from the histopathological study of the tissue sample taken from the right atrium during the operation with the test results. Secondary objectives are to investigate the compatibility of the age-related changes detected histopathologically with chronological age, to reveal which of the Frailty tests used gives better results in predicting mortality, and on the other hand, to reveal the relationship between Frailty tests and STS and Euroscore-II.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2024
CompletedFirst Submitted
Initial submission to the registry
September 6, 2024
CompletedFirst Posted
Study publicly available on registry
January 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedJanuary 20, 2025
January 1, 2025
6 months
September 6, 2024
January 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiac Histopathological Examination
Within the scope of histopathological examination; inflammation and fibrosis criteria in cardiac tissue will be evaluated by the Pathologist and will be interpreted by grading as 0, 1, 2, 3.
Within the following month after the procedure
Other Outcomes (2)
Cardiac Risks Scoring Systems
At the first day of enrollment
Fraility Tests
At the first day of enrollment
Interventions
Coronary Artery Bypass Surgery
Eligibility Criteria
* Patients between the ages of 40 and 80, * Under general anesthesia, planned for elective isolated CABG.
You may qualify if:
- Patients between the ages of 40 and 80,
- Under general anesthesia, planned for elective isolated CABG.
You may not qualify if:
- Under the age of 40, over the age of 80,
- Emergency cases,
- Reoperations,
- Patients with EF ≤ 25%,
- Patients with vasculitis, rheumatological diseases and connective tissue diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Basaksehir Cam ve Sakura City Hospital
Istanbul, Başakşehir, 34480, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zulfiye Yildiz M.D.
Başakşehir Çam & Sakura City Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 6, 2024
First Posted
January 20, 2025
Study Start
September 5, 2024
Primary Completion
March 1, 2025
Study Completion
April 1, 2025
Last Updated
January 20, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share